Evidence map›Paper›PMID 41231848›Full record

ArticlePloS one2025

Optimizing gamma irradiation for mutation breeding in seedless barberry (Berberis vulgaris L.): Establishing LD50 and GR50 thresholds.

Mehri Asadi Zargh Abad, Gholamreza Rabiei, Ali Akbar Ghasemi-Soloklui, Mojtaba Kordrostami, Mohammad Rabiei

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mehri Asadi Zargh AbadDepartment of Horticultural Sciences, Faculty of Agriculture, Shahrekord University, Shahr-e Kord, Iran.
Gholamreza RabieiDepartment of Horticultural Sciences, Faculty of Agriculture, Shahrekord University, Shahr-e Kord, Iran.ORCID https://orcid.org/0000-0003-0248-7193
Ali Akbar Ghasemi-SolokluiNuclear Agriculture Research School, Nuclear Science and Technology Research Institute (NSTRI), Karaj, Iran.ORCID https://orcid.org/0000-0002-3565-8051
Mojtaba KordrostamiNuclear Agriculture Research School, Nuclear Science and Technology Research Institute (NSTRI), Karaj, Iran.
Mohammad RabieiDepartment of Plant Breeding and Biotechnology, Faculty of Agriculture, Shahrekord University, Shahr-e Kord, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Native to Iran, seedless barberry (Berberis vulgaris L.) is a nutritionally and economically important crop prized for its therapeutic uses and food industry applications. Nevertheless, the vegetative propagation of the plant and lack of seeds limit conventional breeding techniques, therefore reducing genetic variation and impeding cultivars improvement. This work sought to maximize gamma radiation dosages to cause mutations in seedless barberry hence increasing genetic variability for breeding projects. Hardwood cuttings were subjected to gamma radiation dosages of 0 (control), 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 Gy using a Cobalt-60 source. Under both in vitro and in vivo settings, the impacts on survival rates, leaf and shoot development, and morphometric features were assessed. Results revealed that rising radiation doses significantly reduced survival rates and growth metrics. The LD50 (Lethal dose) was determined to be roughly 19 Gy for the in vivo and 13.6 Gy for the in vitro. Gamma irradiation negatively influenced plant growth according to values for leaf length, leaf width, fresh weight, and dry weight growth reduction (GR50). Optimal dosages for causing mutations, while preserving survival, were found to be 15 Gy for the in vivo and 10 Gy for the in vitro.

Indexed as

BerberisGamma RaysMutationPlant BreedingLethal Dose 50Plant LeavesSeeds

Identifiers

PMID41231848
PMCPMC12614536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.